We postulate that FWFE can alleviate insulin resistance via inhibiting the intracellular JNK inflammatory signaling cascades, restoring the PI3K-Akt/PKB insulin signaling pathway, and then enhancing glucose uptake in TNF-α-treated FL83B mouse hepatocytes (Figure 5). The gene discussed is AKT1; the disease is Insulin resistance.